VC

Victor Chong

Chief Medical Officer, EVP

Clearside Biomedical, Inc.

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Clearside Biomedical, Inc.
Industry
research
Employees
41.0
Seniority
C suite
Annual Revenue
1664000.0

Technologies

Outlook Google Cloud Hosting Google Analytics Mobile Friendly Google Tag Manager Google Font API WordPress.org Nginx New Relic Render IoT Remote Circle AI

Keywords

ophthalmology retinal disease uveitis diabetic macular edema wetamd suprachoroidal space biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research scs microinjector ophthalmic therapy macular edema uveitis treatment fda-approved product traimcinolone acetonide neovascular amd gene therapy injection platform innovative delivery system clinical trials patient outcomes surgical alternative non-surgical procedure small molecule therapies collaborative partnerships wet amd geographic atrophy therapeutic agents retention of vision vision preservation eye health innovations corticosteroid suspension therapeutic injections ocular conditions clinical development regulatory expertise market potential patient benefits retinal diseases compartmentalized delivery pipeline overview translational medicine pharmaceutical advancements biopharmaceutical company therapeutic delivery vision loss prevention chronic eye diseases innovative treatment solutions research collaborations long-acting treatments scs injection platform macula delivery choroid treatments retina therapies vision improvement strategies health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans